data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Opiant Pharma
(NASDAQ:OPNT)
$11.95
-0.04[-0.33%]
At close: Jul 1
$11.99
0.0400[0.33%]
After Hours: 4:40PM EDT
Day High/Low11.5 - 12.49
52 Week High/Low7.34 - 37.71
Open / Close11.97 / 11.95
Float / Outstanding4.8M / 5.1M
Vol / Avg.11.1K / 89.3K
Mkt Cap60.8M
P/E-
50d Avg. Price14.42
Div / Yield-
Payout Ratio-
EPS-2.43
Total Float4.8M

Opiant Pharma (NASDAQ:OPNT), Quotes and News Summary

Opiant Pharma (NASDAQ: OPNT)

Day High/Low11.5 - 12.49
52 Week High/Low7.34 - 37.71
Open / Close11.97 / 11.95
Float / Outstanding4.8M / 5.1M
Vol / Avg.11.1K / 89.3K
Mkt Cap60.8M
P/E-
50d Avg. Price14.42
Div / Yield-
Payout Ratio-
EPS-2.43
Total Float4.8M
Benzinga - Jun 8, 2022, 4:11PM
Benzinga - Jun 1, 2022, 4:08PM
Benzinga - May 13, 2022, 9:45AM
Benzinga - May 12, 2022, 11:30AM
Benzinga - May 11, 2022, 1:05PM
Benzinga - May 11, 2022, 1:00PM
Benzinga - May 10, 2022, 4:15PM
Benzinga - Apr 29, 2022, 1:53PM
Benzinga - Apr 29, 2022, 12:50PM
Benzinga - Apr 29, 2022, 12:11PM
Benzinga - Apr 29, 2022, 11:33AM
Benzinga - Apr 29, 2022, 10:43AM
Benzinga - Apr 29, 2022, 10:39AM
Benzinga - Apr 28, 2022, 8:51AM
Benzinga - Apr 27, 2022, 4:16PM
Benzinga - Mar 17, 2022, 3:20PM
Benzinga - Mar 15, 2022, 4:09PM
Benzinga - Mar 11, 2022, 2:33PM
Benzinga - Feb 10, 2022, 12:54PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. The company's pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD) and Acute Cannabinoid Overdose (ACO). The majority of the revenue is generated in the form of Royalty and licensing.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-2.430
REV5.900M4.470M-1.430M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Opiant Pharma Questions & Answers

Q
How do I buy Opiant Pharma (OPNT) stock?
A

You can purchase shares of Opiant Pharma (NASDAQ: OPNT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Opiant Pharma's (OPNT) competitors?
Q
What is the target price for Opiant Pharma (OPNT) stock?
A

The latest price target for Opiant Pharma (NASDAQ: OPNT) was reported by Oppenheimer on Thursday, December 9, 2021. The analyst firm set a price target for 42.00 expecting OPNT to rise to within 12 months (a possible 251.46% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Opiant Pharma (OPNT)?
A

The stock price for Opiant Pharma (NASDAQ: OPNT) is $11.95 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Opiant Pharma (OPNT) pay a dividend?
A

There are no upcoming dividends for Opiant Pharma.

Q
When is Opiant Pharma (NASDAQ:OPNT) reporting earnings?
A

Opiant Pharma’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Opiant Pharma (OPNT) going to split?
A

There is no upcoming split for Opiant Pharma.

Q
What sector and industry does Opiant Pharma (OPNT) operate in?
A

Opiant Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.